Exhibit

We consent to the reference to our firm under the caption "Experts" in this Registration Statement (Form S-3) and related Prospectus of Pieris Pharmaceuticals, Inc. for the registration of common stock, preferred stock, debt securities, warrants, rights, purchase contracts and units and to the incorporation by reference therein of our report dated March 15, 2018, with respect to the consolidated financial statements of Pieris Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2017, filed with the Securities and Exchange Commission.




/s/ Ernst & Young LLP